Cognition Therapeutics, Inc. (CGTX) Tops Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts CGTX Hot Sheet
Join SI Premium – FREE
Cognition Therapeutics, Inc. (NASDAQ: CGTX) reported Q2 EPS of ($0.18), $0.05 better than the analyst estimate of ($0.23).
For earnings history and earnings-related data on Cognition Therapeutics, Inc. (CGTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- US Eyes 7.5% China Overcapacity Tariffs Before Xi-Trump Talks - Bloomberg
- Active options: NVDA TSLA AAPL MU INTC AMZN SPCX MSTR GOOGL AMD
- Deutsche Bank Downgrades argenx SE (ARGX:BB) (ARGX) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
